<DOC>
	<DOCNO>NCT00747409</DOCNO>
	<brief_summary>Compared human insulin analogue insulin offer option optimize metabolism also type 2 diabetes . Especially , fast act insulin analogue lower postprandial glucose level effectively human regular insulin . However , know whether therapy analogue insulin also improve subclinically impaired myocardial function type 2 diabetes . This prospective , randomize , open long term study compare effect basal-bolus insulin therapy analogue insulin versus human insulin metabolic control systolic diastolic myocardial function , test hypothesis optimize postprandial glucose control improve cardiac function cardiovascular risk .</brief_summary>
	<brief_title>Insulin Effects Metabolism Cardiovascular Function Type 2 Diabetes</brief_title>
	<detailed_description>This single centre , long term ( 24-48 month ) , therapy control randomise study blind analysis ultrasound data 120 patient type 2 diabetes mellitus previous insulin therapy . After recruitment informed consent , patient randomize two treatment arm accord randomisation protocol take account age absence presence cardiovascular event patient 's history . In one treatment arm , intensive insulin therapy base human insulin ( insulin NPH regular human insulin ) arm , intensive insulin therapy base analogue insulin ( insulin detemir insulin aspart ) . Both treatment arm titrate identical glycemic goal ( fast blood glucose &lt; 110 mg/dL post prandial blood glucose &lt; 150 mg/dL ) . All patient update skill self medication departmental diabetic teaching programme und receive life style instruction visit . Furthermore , encourage keep record episode hypoglycemia throughout study . Outpatient visit metabolic control every 3 month ultrasound blood test every 6 month .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>type 2 diabetes , insulin therapy type 1 diabetes , BMI &gt; 40 , pregnancy ,</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>postprandial glucose , diastolic function , analogue insulin</keyword>
</DOC>